methazolamide has been researched along with Mastocytosis in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henry, EK | 1 |
| Sy, CB | 1 |
| Inclan-Rico, JM | 1 |
| Espinosa, V | 1 |
| Ghanny, SS | 1 |
| Dwyer, DF | 1 |
| Soteropoulos, P | 1 |
| Rivera, A | 1 |
| Siracusa, MC | 1 |
1 other study available for methazolamide and Mastocytosis
| Article | Year |
|---|---|
Carbonic anhydrase enzymes regulate mast cell-mediated inflammation.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Immunoglobulin E; Inflammation; Mast Ce | 2016 |